pyrazolanthrone has been researched along with cyclin d1 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, BL; Bradham, CA; Brenner, DA; Hatano, E; Schoonhoven, R; Schwabe, RF; Uehara, T | 1 |
| Lu, Q; Qiu, TQ; Yang, H | 1 |
| Kang, S; Kwon, KS; Suh, HW | 1 |
| Chen, LM; Chen, YS; Fang, WK; Huang, CY; Ko, FY; Kuo, CH; Kuo, WW; Tsai, CH; Tsai, FJ; Wang, HL | 1 |
| Che, Y; Deng, Q; Gong, W; Jiang, B; Liang, Y; Peng, L; Qing, H; Wang, W; Wang, X; Zhang, H | 1 |
| Efthimiadi, L; Farso, M; Krantic, S; Quirion, R | 1 |
| Cho, CH; Kan, WL; Lin, G; Rudd, JA; To, KK; Xu, G; Xu, HX; Yin, C | 1 |
| Garg, B; Garg, K; Pathria, G; Wagner, C; Wagner, SN | 1 |
| Bae, H; Bazer, FW; Lim, W; Song, G | 1 |
9 other study(ies) available for pyrazolanthrone and cyclin d1
| Article | Year |
|---|---|
c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration.
Topics: Animals; Anthracenes; Cell Division; Cells, Cultured; Cyclin D1; Enzyme Inhibitors; Hepatectomy; Hepatocytes; JNK Mitogen-Activated Protein Kinases; Liver; Liver Regeneration; Male; Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Survival Rate | 2003 |
Ligustilide inhibits vascular smooth muscle cells proliferation.
Topics: 4-Butyrolactone; Animals; Anthracenes; Blotting, Western; Cell Cycle; Cell Proliferation; Cells, Cultured; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme Activation; Flavonoids; Imidazoles; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphorylation; Pyridines; Rats; Rats, Wistar; Reactive Oxygen Species; Retinoblastoma Protein | 2006 |
Curcumin attenuates glutamate-induced HT22 cell death by suppressing MAP kinase signaling.
Topics: Animals; Anthracenes; Antioxidants; Cell Death; Cell Line; Curcumin; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Glutamic Acid; Glutathione; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Neuroprotective Agents; Oxidative Stress; Phosphorylation; Reactive Oxygen Species; Transcription Factor AP-1 | 2007 |
The proliferation and migration effects of huangqi on RSC96 Schwann cells.
Topics: Animals; Anthracenes; Astragalus Plant; Astragalus propinquus; Blotting, Western; Butadienes; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Cyclin A; Cyclin D1; Cyclin E; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Enzyme Inhibitors; Fibroblast Growth Factor 2; Imidazoles; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 3; Models, Biological; Nitriles; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Reverse Transcriptase Polymerase Chain Reaction; Schwann Cells; Urokinase-Type Plasminogen Activator | 2009 |
PAK1-dependent MAPK pathway activation is required for colorectal cancer cell proliferation.
Topics: Animals; Anthracenes; Antimetabolites, Antineoplastic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Colorectal Neoplasms; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Fluorouracil; G1 Phase; Humans; Immunoblotting; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Mice, Nude; p21-Activated Kinases; PTEN Phosphohydrolase; RNA Interference; Xenograft Model Antitumor Assays | 2012 |
Cyclin D1 induction preceding neuronal death via the excitotoxic NMDA pathway involves selective stimulation of extrasynaptic NMDA receptors and JNK pathway.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anthracenes; Cell Count; Cells, Cultured; Cyclin D1; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Gene Expression Regulation; Hippocampus; Ki-67 Antigen; MAP Kinase Signaling System; N-Methylaspartate; Nerve Tissue Proteins; Neuroglia; Neurons; Rats; Receptors, N-Methyl-D-Aspartate; RNA, Small Interfering; Signal Transduction; Synapses; Time Factors; Transfection | 2012 |
Antitumor effects of novel compound, guttiferone K, on colon cancer by p21Waf1/Cip1-mediated G(0) /G(1) cell cycle arrest and apoptosis.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Benzophenones; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Chromatin; Colonic Neoplasms; Cyclin D1; Cyclin D3; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Fluorouracil; G1 Phase Cell Cycle Checkpoints; Humans; JNK Mitogen-Activated Protein Kinases; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Poly(ADP-ribose) Polymerases | 2013 |
Dual c-Jun N-terminal kinase-cyclin D1 and extracellular signal-related kinase-c-Jun disjunction in human melanoma.
Topics: Anthracenes; Cell Proliferation; Cyclin D1; Humans; JNK Mitogen-Activated Protein Kinases; Melanoma; Protein Kinase Inhibitors; Signal Transduction; Skin Neoplasms; Tumor Cells, Cultured | 2016 |
Ephrin A1 promotes proliferation of bovine endometrial cells with abundant expression of proliferating cell nuclear antigen and cyclin D1 changing the cell population at each stage of the cell cycle.
Topics: Animals; Anthracenes; Butadienes; Cattle; Cell Cycle; Cell Line; Cell Proliferation; Cyclin D1; Endometrium; Endoplasmic Reticulum Stress; Ephrin-A1; Extracellular Signal-Regulated MAP Kinases; Female; Interferon Type I; JNK Mitogen-Activated Protein Kinases; Nitriles; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Pregnancy; Pregnancy Proteins; Proliferating Cell Nuclear Antigen; Receptor, EphA2; Receptor, EphA4; Wortmannin | 2019 |